According to The Financial Supervisory Service's electronic disclosure on May 21, The recorded sales of 1.54 trillion won, up 13.5% from The consolidated level last year.
Operating profit for The same period was 117.8 billion won, up 30.9% (1.3579 trillion won) from The previous year. However, net profit fell 8.6% from 36.8 billion won to 33.6 billion won.
The earnings growth of major subsidiaries such as 'CKM' (CKM) is considered as The background of The earnings growth. CKeiM is The parent company of cj healthcare, which The acquired for 1.3 trillion won in 2018.
Specifically, cj healthcare's Kei Capjeong', a New Testament for gastroesophageal reflux disease, was a boost to earnings. Kei Capjeong is The 30th development New Testament in Korea launched in March last year. In addition, The hangover relief agent 'Conditional Transition', which was modeled on actor Park Seo-joon, also played a role as a driving force.
"cj healthcare has led The growth of The 30th New Testament Kei Capjeong (gastroesophageal reflux disease) in Korea with The highest sales," The official said. "Active marketing activities of major products including The condition change of The H & B division also affected sales growth."
The Effect of Earnings Growth of Major Subsidiaries such as CKM